Europe Point-of-Care Molecular Diagnostics Market- Global Drivers, Opportunities, Trends, and Forecasts to 2028

Market Introduction

Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing. Due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes, POCT is rapidly gaining traction.

Moreover, the growing demand for specific viral detection methods that consume less time for timely infection control is expected to bolster the market growth during the forecast period.

๐Ÿ“š ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ@ https://www.businessmarketinsights.com/sample/TIPRE00026190

In Europe, currently, the UK and Russia are the hardest-hit countries by the COVID-19 pandemic, followed by France, Spain, Italy, and Germany. The implementation of drastic measures and travel restrictions, including closing the borders, impacted the import and export of products, especially in the first half of 2020. The continuous spread of the disease has led to an elevated demand for advanced diagnostic solutions in Europe, thus boosting the adoption of point-of-care molecular diagnostic kits. Moreover, uninterrupted investments and business activities by industry players are also boosting the point-of-care molecular diagnostic market growth. In 2020, European Medicines Agency (EMA) approved ~97 medicines for the marketing authorization, of which 39 were novel drugs. In October 2020, Eurofins introduced PCR-based COVID-19 diagnostic tests with at-home, self-sampling options, in the for European market. In January 2020, European Union (EU) commission announced an emergency call, through which it awarded US$ 55.64 million to 18 research projects. Among these, 3 of the projects are receiving a total of US$ 7.39 million to develop effective, rapid point-of-care diagnostics.

๐Ÿ“š๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‹๐ข๐ง๐ค @ https://www.businessmarketinsights.com/reports/europe-point-of-care-molecular-diagnostics-market

๐“๐ก๐ž ๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ

bioMรฉrieux SA

F. Hoffmann-La Roche Ltd.

Danaher Corporation

Enzo Biochem, Inc.

Abbott

binx health, Inc.

Meridian BioScience, Inc.

Biocartis

Quidel Corporation

Bio-Rad Laboratories, Inc

 

·         Segments Covered

By Product & Services

  • Assays and Kits
  • Instruments
  • Services and Software

By Technology

  • PCR
  • Isothermal Nucleic Acid Amplification Technology
  • Other Technologies

By Application

  • Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Other Applications

By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research and Academic Institutes

Major Sources and Companies: A Competitive Landscape

The European POC MDx market is characterized by a mix of established multinational corporations and innovative startups.

  • Major Companies:
    • The listed companies represent a diverse range of expertise in molecular diagnostics, including:
      • bioMรฉrieux SA: A leader in microbiology and infectious disease diagnostics.
      • F. Hoffmann-La Roche Ltd.: A global healthcare giant with a strong presence in molecular diagnostics.
      • Danaher Corporation: A diversified technology company with a portfolio of diagnostic solutions.
      • Abbott: a large diversified medical company.
    • The inclusion of companies like binx health, Inc. highlights the growing importance of innovative startups in the POC MDx market.
  • Sources of Information:
    • The reliance on company websites, annual reports, financial reports, government documents, and statistical databases underscores the importance of both primary and secondary research in market analysis.
    • This variety of sources helps to give a complete and accurate view of the market.

Key Considerations:

  • The market is dynamic, and the relative share of each segment may shift over time.
  • Technological advancements and evolving healthcare needs will continue to shape the market landscape.
  • Regulatory changes can also have a very large impact on this market.

By understanding these key market segments and the competitive landscape, stakeholders can gain valuable insights into the opportunities and challenges in the European POC MDx market.

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

 

 

Comments

Popular posts from this blog

Europe Power Management IC Market Major Manufacturers, Trends, Demand, Share Analysis to 2028

North America Industrial Insulation Market Drivers, Opportunities, Trends, and Forecasts by 2028

Europe Food Contact Paper Market Analysis, Segments, Key Players, Drivers, Trends by Forecast 2022 to 2028